Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions)

Clinical trial NCT07290244 · RECRUITING

Trial details

NCT number: NCT07290244
Sponsor: Life Biosciences Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Open Angle Glaucoma (OAG)NAION( Non-arteritic Anterior Ischemic Optic Neuropathy)

Start date: 2026-03-02
Primary completion: 2027-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.